DrugChEMBL
Acetohydroxamic Acid
Total Trials
2
Max Phase
-
Type
DRUG
Molecule
Small molecule
Registry-listed formulations
acetohydroxamic acid · mesh:C006358
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- Acetohydroxamic Acid Oral TabletRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Phase 1/2
1
50%
Phase 2
1
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1/2Combined phases
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Terminated(1)
Detailed Status
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 1/21 (50.0%)
Phase 21 (50.0%)
Trials by Status
not_yet_recruiting150%
terminated150%
Recent Activity
Clinical Trials (2)
Drug Details
- Intervention Type
- Drug
- Molecule Type
- Small molecule
- Total Trials
- 2
External References
ChEMBL
CHEMBL734